Spots Global Cancer Trial Database for amgen
Every month we try and update this database with for amgen cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer | NCT00393822 | Colon Cancer | palifermin placebo | 18 Years - | Amgen | |
| Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies | NCT00239239 | Non-Myeloid Mal... Anemia Cancer | Darbepoetin alf... | 18 Years - | Amgen | |
| Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer | NCT00322400 | Locally Recurre... | Docetaxel Paclitaxel AMG 706 | 18 Years - | Amgen | |
| Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy | NCT00120679 | Non-Small Cell ... Anemia | darbepoetin alf... recombinant hum... | 18 Years - | Amgen | |
| Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid Tumors | NCT00448786 | Solid Tumors | AMG 706 AMG 706 AMG 706 | 18 Years - | Amgen | |
| Single Dose Study of [14C]-Labelled AMG 706 in Patients With Advanced Solid Tumors | NCT01386866 | Advanced Solid ... | AMG 706 | 18 Years - | Amgen | |
| Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia | NCT01380756 | Cancer Hematologic Mal... Leukemia Myeloid Leukemi... | Arm 1- Dose Esc... Arm 2- Dose Exp... | 18 Years - | Amgen | |
| QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid Tumors | NCT00974896 | Advanced Malign... Advanced Solid ... Cancer Solid Tumors Tumors | AMG 479 | 18 Years - | NantCell, Inc. | |
| PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy | NCT00364013 | Metastatic Colo... | Panitumumab FOLFOX regimen | 18 Years - | Amgen | |
| A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer | NCT00393822 | Colon Cancer | palifermin placebo | 18 Years - | Amgen | |
| A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors | NCT00858377 | Advanced Malign... Advanced Solid ... Cancer Solid Tumors Tumors | Arm 1- Dose Esc... Arm 1- Dose Exp... | 18 Years - | Amgen | |
| Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy | NCT00111137 | Cancer Non-Myeloid Mal... | rHuEPO Darbepoetin alf... | 18 Years - | Amgen | |
| A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer | NCT00131638 | Head and Neck C... | Placebo Palifermin | 18 Years - | Amgen | |
| TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer | NCT01204749 | Fallopian Tube ... Ovarian Cancer Primary Periton... | AMG 386 AMG 386 Placebo Paclitaxel Paclitaxel | 18 Years - | Amgen | |
| Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma | NCT00115193 | Non-Hodgkin's L... | pegfilgrastim pegfilgrastim | 18 Years - | Amgen | |
| QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid Tumors | NCT00974896 | Advanced Malign... Advanced Solid ... Cancer Solid Tumors Tumors | AMG 479 | 18 Years - | NantCell, Inc. | |
| A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer | NCT00131638 | Head and Neck C... | Placebo Palifermin | 18 Years - | Amgen | |
| A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer | NCT00393822 | Colon Cancer | palifermin placebo | 18 Years - | Amgen | |
| Study of Blinatumomab in Japanese Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia | NCT02412306 | Relapsed Refrac... | Blinatumomab | 0 Years - | Amgen | |
| A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp® | NCT00117117 | Anemia | Aranesp | 18 Years - | Amgen | |
| AIM 3: Anemia and Iron Management With Every 3 Week Dosing in Anemic Subjects With Nonmyeloid Malignancies | NCT00135317 | Cancer | darbepoetin alf... | 18 Years - | Amgen | |
| Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone | NCT00339183 | Metastatic Colo... | Panitumumab FOLFIRI | 18 Years - | Amgen | |
| Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy | NCT00120705 | Neoplasms Anemia | darbepoetin alf... | 18 Years - | Amgen | |
| Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies | NCT00239239 | Non-Myeloid Mal... Anemia Cancer | Darbepoetin alf... | 18 Years - | Amgen | |
| Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy | NCT00121030 | Gynecological M... Genital Neoplas... Anemia | darbepoetin alf... recombinant hum... | 18 Years - | Amgen | |
| A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer | NCT00131638 | Head and Neck C... | Placebo Palifermin | 18 Years - | Amgen | |
| Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid Tumors | NCT00448786 | Solid Tumors | AMG 706 AMG 706 AMG 706 | 18 Years - | Amgen | |
| Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies | NCT00239239 | Non-Myeloid Mal... Anemia Cancer | Darbepoetin alf... | 18 Years - | Amgen | |
| PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy | NCT00364013 | Metastatic Colo... | Panitumumab FOLFOX regimen | 18 Years - | Amgen | |
| Treatment for Patients Suffering From Anemia Due to Chemotherapy | NCT00120692 | Breast Cancer Anemia | Darbepoetin Alf... Recombinant Hum... | 18 Years - | Amgen | |
| Evaluating Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy | NCT00083616 | Colorectal Canc... Metastatic Canc... | Panitumumab | 18 Years - | Amgen | |
| Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy | NCT00115206 | Non-Small Cell ... | Neulasta® (pegf... | 18 Years - | Amgen | |
| Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy | NCT00120705 | Neoplasms Anemia | darbepoetin alf... | 18 Years - | Amgen | |
| Treatment for Patients Suffering From Anemia Due to Chemotherapy | NCT00120692 | Breast Cancer Anemia | Darbepoetin Alf... Recombinant Hum... | 18 Years - | Amgen | |
| Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy | NCT00115206 | Non-Small Cell ... | Neulasta® (pegf... | 18 Years - | Amgen | |
| Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma | NCT00115193 | Non-Hodgkin's L... | pegfilgrastim pegfilgrastim | 18 Years - | Amgen | |
| Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium | NCT00896454 | Breast Cancer Hypercalcemia o... Colon Cancer Endocrine Cance... Head and Neck C... Kidney Cancer Lung Cancer Lymphoma Metastatic Canc... Multiple Myelom... Parathyroid Neo... Renal Cancer Thyroid Cancer Hodgkin's Lymph... Non-Hodgkin's L... Non-Small Cell ... | denosumab | 18 Years - | Amgen |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
